GUJTHEM

Gujarat Themis Biosyn Limited

Fermentation-based pharma platform for APIs and intermediates

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

gtbl.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-19

Stock price
₹358.65
Market cap
4,668 Cr
Stock P/E
79.9
P/B
13.58
Dividend yield
0.2%
ROE (FY26)
16.2%
ROCE (FY26)
14.5%
Operating margin (FY26)
37.8%
Debt / equity (FY26)
0.56
OCF / EBITDA (FY26)
64.6%
OCF / EBITDA (3Y)
91.4%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Gujarat Themis Biosyn (GTBL) makes fermentation-based pharmaceutical intermediates and active pharmaceutical ingredients (APIs) at its plant in Gujarat, selling mainly to domestic pharmaceutical companies that make finished medicines.

Company snapshot

63rdBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓Net margin of 28.2% — the business keeps a healthy share of every rupee it earns.
2 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales40 Cr39 Cr42 Cr39 Cr35 Cr40 Cr38 Cr36 Cr42 Cr43 Cr44 Cr44 Cr
Operating expenses (approx.)23 Cr21 Cr21 Cr20 Cr19 Cr21 Cr22 Cr22 Cr21 Cr22 Cr25 Cr23 Cr
EBITDA17 Cr18 Cr21 Cr19 Cr15 Cr19 Cr16 Cr14 Cr21 Cr21 Cr19 Cr21 Cr
OPM %42.4%45.7%49.8%47.8%44.3%47.7%42.5%38.8%49.5%49.1%43.8%47.5%
Other income1 Cr1 Cr1 Cr0.52 Cr0.32 Cr0.24 Cr1 Cr0.27 Cr0.82 Cr0.42 Cr0.92 Cr0.13 Cr
Interest0.05 Cr0.08 Cr0.07 Cr0.07 Cr0.08 Cr0.14 Cr0.07 Cr0.04 Cr0.04 Cr0.96 Cr2 Cr2 Cr
Depreciation0.88 Cr0.98 Cr0.92 Cr1 Cr1 Cr2 Cr1 Cr2 Cr3 Cr4 Cr4 Cr4 Cr
Profit before tax17 Cr18 Cr21 Cr18 Cr14 Cr17 Cr16 Cr12 Cr19 Cr17 Cr14 Cr15 Cr
Tax %25.7%26.5%24.2%25.9%25.5%25.4%25.4%25.2%24.0%26.1%24.0%27.0%
Net profit13 Cr13 Cr16 Cr13 Cr11 Cr13 Cr12 Cr9 Cr14 Cr12 Cr11 Cr11 Cr
EPS (₹)₹8.63₹1.79₹2.19₹1.82₹0.97₹1.19₹1.10₹0.83₹1.31₹1.14₹1.00₹1.02

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales36 Cr39 Cr41 Cr85 Cr91 Cr115 Cr149 Cr170 Cr151 Cr166 CrSign in free for the trailing twelve months
Operating expenses (approx.)30 Cr33 Cr34 Cr53 Cr50 Cr57 Cr75 Cr91 Cr82 Cr90 CrSign in free for the trailing twelve months
EBITDA6 Cr6 Cr7 Cr32 Cr40 Cr58 Cr74 Cr79 Cr69 Cr76 CrSign in free for the trailing twelve months
OPM %16.9%16.1%17.9%37.4%44.5%50.5%49.8%46.4%45.7%45.5%Sign in free for the trailing twelve months
Other income0.36 Cr0.17 Cr2 Cr2 Cr3 Cr4 Cr6 Cr4 Cr2 Cr2 CrSign in free for the trailing twelve months
Interest0.41 Cr0.42 Cr0.13 Cr0.92 Cr0.98 Cr0.83 Cr0.20 Cr0.23 Cr0.36 Cr3 CrSign in free for the trailing twelve months
Depreciation1 Cr1 Cr1 Cr1 Cr2 Cr2 Cr3 Cr4 Cr5 Cr13 CrSign in free for the trailing twelve months
Profit before tax5 Cr5 Cr8 Cr31 Cr41 Cr59 Cr77 Cr79 Cr66 Cr62 CrSign in free for the trailing twelve months
Tax %10.4%20.1%21.8%24.3%26.2%26.1%25.2%25.4%25.6%24.8%Sign in free for the trailing twelve months
Net profit4 Cr4 Cr6 Cr24 Cr30 Cr44 Cr58 Cr59 Cr49 Cr47 CrSign in free for the trailing twelve months
EPS (₹)₹3.01₹2.66₹4.41₹16.30₹20.77₹30.03₹39.90₹8.14₹4.48₹4.28Sign in free for the trailing twelve months
Dividend payout %————7.9%22.9%21.5%11.7%3.7%15.6%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital7 Cr7 Cr7 Cr7 Cr7 Cr7 Cr7 Cr7 Cr11 Cr11 Cr
Reserves0.95 Cr5 Cr11 Cr35 Cr63 Cr96 Cr142 Cr194 Cr237 Cr277 Cr
Borrowings2 Cr—0.01 Cr3 Cr————30 Cr160 Cr
Other liabilities11 Cr8 Cr14 Cr19 Cr18 Cr19 Cr17 Cr20 Cr23 Cr56 Cr
Total liabilities21 Cr20 Cr33 Cr64 Cr88 Cr123 Cr166 Cr221 Cr301 Cr503 Cr
Fixed assets (net)11 Cr11 Cr15 Cr17 Cr17 Cr18 Cr32 Cr35 Cr41 Cr287 Cr
CWIP0.20 Cr0.17 Cr0.95 Cr0.36 Cr2 Cr13 Cr21 Cr91 Cr184 Cr121 Cr
Investments0.0050 Cr0.0050 Cr0.0050 Cr0.0050 Cr0 Cr0 Cr0 Cr0 Cr0 Cr3 Cr
Loans & advances——0.0007 Cr0.02 Cr0.02 Cr18 Cr18 Cr0.0023 Cr0.0035 Cr0.0063 Cr
Inventories0.51 Cr0.46 Cr0.34 Cr6 Cr6 Cr12 Cr15 Cr3 Cr5 Cr15 Cr
Trade receivables7 Cr3 Cr6 Cr20 Cr15 Cr25 Cr18 Cr27 Cr31 Cr61 Cr
Cash & bank0.13 Cr0.89 Cr1 Cr0.86 Cr4 Cr0.46 Cr6 Cr6 Cr12 Cr3 Cr
Other assets3 Cr6 Cr10 Cr19 Cr44 Cr37 Cr57 Cr58 Cr28 Cr13 Cr
Total assets21 Cr20 Cr33 Cr64 Cr88 Cr123 Cr166 Cr221 Cr301 Cr503 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity3 Cr6 Cr0.69 Cr0.63 Cr11 Cr40 Cr40 Cr64 Cr91 Cr49 Cr
Cash from investing-3 Cr-1 Cr-6 Cr-3 Cr-2 Cr-30 Cr-20 Cr-55 Cr-112 Cr-172 Cr
Cash from financing-0.19 Cr-4 Cr5 Cr2 Cr-5 Cr-14 Cr-13 Cr-9 Cr26 Cr115 Cr
Net cash flow0.10 Cr0.76 Cr0.23 Cr-0.26 Cr3 Cr-4 Cr6 Cr0.41 Cr5 Cr-9 Cr
Free cash flow (OCF − Capex)0.26 Cr5 Cr-11 Cr-3 Cr7 Cr26 Cr16 Cr-10 Cr-25 Cr-124 Cr

Ratios

No data for this view.